These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 17014938)
1. Exposure of Ugandan health personnel to measles and rubella: evidence of the need for health worker vaccination. Lewis RF; Braka F; Mbabazi W; Makumbi I; Kasasa S; Nanyunja M Vaccine; 2006 Nov; 24(47-48):6924-9. PubMed ID: 17014938 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B infection among health workers in Uganda: evidence of the need for health worker protection. Braka F; Nanyunja M; Makumbi I; Mbabazi W; Kasasa S; Lewis RF Vaccine; 2006 Nov; 24(47-48):6930-7. PubMed ID: 17027122 [TBL] [Abstract][Full Text] [Related]
3. Healthcare workers and immunity to infectious diseases. Vagholkar S; Ng J; Chan RC; Bunker JM; Zwar NA Aust N Z J Public Health; 2008 Aug; 32(4):367-71. PubMed ID: 18782402 [TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of prevaccination screening of health care workers for immunity to measles, rubella and mumps. Ferson MJ; Robertson PW; Whybin LR Med J Aust; 1994 Apr; 160(8):478-82. PubMed ID: 8170422 [TBL] [Abstract][Full Text] [Related]
5. Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective? Celikbas A; Ergonul O; Aksaray S; Tuygun N; Esener H; Tanir G; Eren S; Baykam N; Guvener E; Dokuzoguz B Am J Infect Control; 2006 Nov; 34(9):583-7. PubMed ID: 17097453 [TBL] [Abstract][Full Text] [Related]
6. [Seroprevalence of measles, rubella, mumps and varicella in health workers in the Community of Madrid]. Rodríguez ML; Martínez D; Santos-Sancho JM; Borda JR; Orero A Rev Esp Quimioter; 2014 Jun; 27(2):98-101. PubMed ID: 24940889 [TBL] [Abstract][Full Text] [Related]
7. Rubella and measles seroprevalence among women of childbearing age, Argentina, 2002. Dayan GH; Panero MS; Urquiza A; Molina M; Prieto S; Del Carmen Perego M; Scagliotti G; Galimberti D; Carroli G; Wolff C; Bi D; Bellini W; Icenogle J; Reef S Epidemiol Infect; 2005 Oct; 133(5):861-9. PubMed ID: 16181506 [TBL] [Abstract][Full Text] [Related]
8. [Immunity coverage against measles, rubella and parotiditis viruses in a juvenile population in Leon, Spain]. Suárez J; Castañeda MR; Gutiérrez CB; Rodríguez Barbosa JI; Tascón RI; Rodríguez Ferri EF Med Clin (Barc); 1993 Oct; 101(13):484-7. PubMed ID: 8231381 [TBL] [Abstract][Full Text] [Related]
9. Seroprevalence survey of varicella, measles, rubella, and hepatitis A and B viruses in a multinational healthcare workforce in Saudi Arabia. Almuneef MA; Memish ZA; Balkhy HH; Otaibi B; Helmi M Infect Control Hosp Epidemiol; 2006 Nov; 27(11):1178-83. PubMed ID: 17080374 [TBL] [Abstract][Full Text] [Related]
10. Progress in measles and rubella elimination in Iran. Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy. Sultana R; Rahman MM; Hassan Z; Hassan MS Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626 [TBL] [Abstract][Full Text] [Related]
12. Progress in Italy in control and elimination of measles and congenital rubella. Bonanni P; Bechini A; Boccalini S; Peruzzi M; Tiscione E; Boncompagni G; Mannelli F; Salmaso S; Filia A; Ciofi degli Atti M Vaccine; 2007 Apr; 25(16):3105-10. PubMed ID: 17306425 [TBL] [Abstract][Full Text] [Related]
13. Serosurveillance of vaccine preventable diseases and hepatitis C in healthcare workers from Lao PDR. Black AP; Vilivong K; Nouanthong P; Souvannaso C; Hübschen JM; Muller CP PLoS One; 2015; 10(4):e0123647. PubMed ID: 25874696 [TBL] [Abstract][Full Text] [Related]
15. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt? Abbassy AA; Barakat SS; Abd El Fattah MM; Said ZN; El Metwally HA East Mediterr Health J; 2009; 15(1):85-93. PubMed ID: 19469430 [TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of rubella infection after national immunization program in Taiwan: vaccination status and immigration impact. Wang IJ; Huang LM; Chen HH; Hwang KC; Chen CJ J Med Virol; 2007 Jan; 79(1):97-103. PubMed ID: 17133552 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine. Hachiya M; Miyano S; Mori Y; Vynnycky E; Keungsaneth P; Vongphrachanh P; Xeuatvongsa A; Sisouk T; Som-Oulay V; Khamphaphongphane B; Sengkeopaseuth B; Pathammavong C; Phounphenghak K; Kitamura T; Takeda M; Komase K PLoS One; 2018; 13(3):e0194931. PubMed ID: 29596472 [TBL] [Abstract][Full Text] [Related]
19. [Antibody development and frequency of events temporarily associated with measles and rubella vaccines among university health personnel in Jalisco]. Villaseñor-Sierra A; Santos-Preciado JI; Alvarez-y-Muñoz MT; Rivas-García ME; Martínez-Sandoval F; Falcón-Franco MA Gac Med Mex; 2005; 141(6):455-9. PubMed ID: 16381498 [TBL] [Abstract][Full Text] [Related]
20. Immune status of health care personnel & post vaccination analysis of immunity against rubella in an eye hospital. Rajasundari TA; Chandrasekar K; Vijayalakshmi P; Muthukkaruppan V Indian J Med Res; 2006 Nov; 124(5):553-8. PubMed ID: 17213524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]